Showing 1 - 5 results of 5 for search 'Maria Vittoria Cossu', query time: 0.03s Refine Results
  1. 1
    Analysis and clinical determinants of post-COVID-19 syndrome in the Lombardy region: evidence from a longitudinal cohort study

    Analysis and clinical determinants of post-COVID-19 syndrome in the Lombardy region: evidence from a longitudinal cohort study by Giuliano Rizzardini, Maria Vittoria Cossu, Chiara Mariani, Fabio Borgonovo, Pietro Giorgio Lovaglio, Paolo Berta, Giorgio Vittadini, Amedeo Ferdinando Capetti

    Published 2024-02-01
    Get full text
    Article
  2. 2
    Switch to Dolutegravir plus Rilpivirine Dual Therapy in cART-Experienced Subjects: An Observational Cohort.

    Switch to Dolutegravir plus Rilpivirine Dual Therapy in cART-Experienced Subjects: An Observational Cohort. by Amedeo F Capetti, Gaetana Sterrantino, Maria Vittoria Cossu, GianCarlo Orofino, Giorgio Barbarini, Giuseppe V De Socio, Simona Di Giambenedetto, Antonio Di Biagio, Benedetto M Celesia, Barbara Argenteri, Giuliano Rizzardini

    Published 2016-01-01
    Get full text
    Article
  3. 3
    Decay rate of antiS1/S2 IgG serum levels after 6 months of BNT162b2 vaccination in a cohort of COVID-19-naive and COVID-19-experienced subjects

    Decay rate of antiS1/S2 IgG serum levels after 6 months of BNT162b2 vaccination in a cohort of COVID-19-naive and COVID-19-experienced subjects by Fabio Borgonovo, Carlo Alberto Stangalini, Carmine Tinelli, Chiara Mariani, Davide Mileto, Maria Vittoria Cossu, Laura Abbati, Lara Bilardo, Gloria Gagliardi, Miriam Cutrera, Martina Pellicciotta, Luciana Armiento, Gianfranco Dedivitiis, Amedeo F. Capetti, Giuliano Rizzardini

    Published 2022-11-01
    Get full text
    Article
  4. 4
    96-week results of a dual therapy with darunavir/ritonavir plus rilpivirine once a day vs triple therapy in patients with suppressed viraemia: virological success and non-HIV related morbidity evaluation

    96-week results of a dual therapy with darunavir/ritonavir plus rilpivirine once a day vs triple therapy in patients with suppressed viraemia: virological success and non-HIV relat... by Valentina Di Cristo, Fulvio Adorni, Renato Maserati, Marco Annovazzi Lodi, Giuseppe Bruno, Paolo Maggi, Anna Volpe, Paola Vitiello, Clara Abeli, Stefano Bonora, Micol Ferrara, Maria Vittoria Cossu, Maria Letizia Oreni, Elisa Colella, Stefano Rusconi

    Published 2020-01-01
    Get full text
    Article
  5. 5
    A dual regimen of ritonavir/darunavir plus dolutegravir for rescue or simplification of rescue therapy: 48 weeks’ observational data

    A dual regimen of ritonavir/darunavir plus dolutegravir for rescue or simplification of rescue therapy: 48 weeks’ observational data by Amedeo F. Capetti, Maria Vittoria Cossu, Giancarlo Orofino, Gaetana Sterrantino, Giovanni Cenderello, Giuseppe V. De Socio, Anna Maria Cattelan, Alessandro Soria, Stefano Rusconi, Niccolò Riccardi, Gian Maria Baldin, Fosca P. Niero, Giorgio Barbarini, Giuliano Rizzardini

    Published 2017-09-01
    Get full text
    Article

Search Tools: